Gaetano Saggio

585 total citations
28 papers, 468 citations indexed

About

Gaetano Saggio is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gaetano Saggio has authored 28 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 8 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gaetano Saggio's work include Cancer Treatment and Pharmacology (8 papers), Lung Cancer Research Studies (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Gaetano Saggio is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), Lung Cancer Research Studies (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Gaetano Saggio collaborates with scholars based in Italy, Colombia and Guatemala. Gaetano Saggio's co-authors include Silvio Rea, F. Recchia, Alisia Cesta, Giampiero Candeloro, Anna Di Blasio, Antonio Nuzzo, Gigliola Sica, G Carta, Stefano Necozione and Marco Lombardo and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

Gaetano Saggio

28 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gaetano Saggio Italy 13 210 188 144 94 86 28 468
Pietro Del Medico Italy 9 207 1.0× 171 0.9× 52 0.4× 61 0.6× 112 1.3× 15 420
Alisia Cesta Italy 11 192 0.9× 104 0.6× 85 0.6× 54 0.6× 56 0.7× 20 339
Maria Elena Guerrieri Italy 13 169 0.8× 166 0.9× 71 0.5× 113 1.2× 128 1.5× 27 535
Michela Ballardini Italy 11 152 0.7× 102 0.5× 46 0.3× 47 0.5× 159 1.8× 16 347
Michael A. Bidus United States 12 104 0.5× 177 0.9× 37 0.3× 89 0.9× 102 1.2× 21 441
Shinichi Tate Japan 14 144 0.7× 225 1.2× 63 0.4× 84 0.9× 244 2.8× 61 528
Nisreen Abu Shahin Jordan 12 62 0.3× 171 0.9× 47 0.3× 138 1.5× 67 0.8× 40 466
Maria Grazia Cantù Italy 9 106 0.5× 437 2.3× 183 1.3× 69 0.7× 223 2.6× 16 574
Heng Cui China 15 67 0.3× 394 2.1× 78 0.5× 94 1.0× 84 1.0× 47 545
Paweł Basta Poland 15 107 0.5× 200 1.1× 73 0.5× 72 0.8× 40 0.5× 49 544

Countries citing papers authored by Gaetano Saggio

Since Specialization
Citations

This map shows the geographic impact of Gaetano Saggio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaetano Saggio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaetano Saggio more than expected).

Fields of papers citing papers by Gaetano Saggio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaetano Saggio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaetano Saggio. The network helps show where Gaetano Saggio may publish in the future.

Co-authorship network of co-authors of Gaetano Saggio

This figure shows the co-authorship network connecting the top 25 collaborators of Gaetano Saggio. A scholar is included among the top collaborators of Gaetano Saggio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaetano Saggio. Gaetano Saggio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Recchia, F., Gaetano Saggio, Anna Di Blasio, et al.. (2007). A multicenter phase II study of pegylated liposomal doxorubicin and oxaliplatin in recurrent ovarian cancer. Gynecologic Oncology. 106(1). 164–169. 19 indexed citations
2.
Recchia, F., Gaetano Saggio, Anna Di Blasio, et al.. (2007). Multicenter Phase II Study of Chemo-immunotherapy in the Treatment of Metastatic Renal Cell Carcinoma. Journal of Immunotherapy. 30(4). 448–454. 10 indexed citations
3.
Recchia, F., Gaetano Saggio, Giampiero Candeloro, et al.. (2007). Chemoimmunotherapy in the treatment of metastatic gastric cancer. Anti-Cancer Drugs. 18(5). 597–604. 6 indexed citations
4.
Recchia, F., Gaetano Saggio, Alisia Cesta, et al.. (2006). Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.. PubMed. 26(3B). 2317–24. 3 indexed citations
5.
Recchia, F., Gaetano Saggio, Alisia Cesta, et al.. (2006). Phase II study of interleukin-2 and 13-cis-retinoic acid as maintenance therapy in metastatic colorectal cancer. Cancer Immunology Immunotherapy. 56(5). 699–708. 23 indexed citations
6.
Recchia, F., Gaetano Saggio, Alisia Cesta, Giampiero Candeloro, & Silvio Rea. (2005). Paclitaxel plus gemcitabine in advanced non-small cell lung cancer patients with low performance status.. PubMed. 25(1B). 409–14. 5 indexed citations
7.
8.
Recchia, F., Gaetano Saggio, Antonio Nuzzo, et al.. (2005). Multicenter Phase 2 Study of Interleukin-2 and 13-Cis Retinoic Acid as Maintenance Therapy in Advanced Non-Small-Cell Lung Cancer. Journal of Immunotherapy. 29(1). 87–94. 23 indexed citations
9.
Recchia, F., Silvio Rea, Antonio Nuzzo, et al.. (2004). Oxaliplatin fractionated over two days with bimonthly leucovorin and 5-fluorouracil in metastatic colorectal cancer.. PubMed. 24(3b). 1935–40. 5 indexed citations
10.
Recchia, F., Gaetano Saggio, Antonio Nuzzo, et al.. (2004). Multicentre phase II study of bifractionated CPT-11 with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer pretreated with FOLFOX. British Journal of Cancer. 91(8). 1442–1446. 12 indexed citations
11.
Recchia, F., Antonio Nuzzo, Liberato Di Lullo, et al.. (2003). Multicenter phase II study of CPT-11 fractionated over two days with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer.. PubMed. 23(3C). 2903–8. 7 indexed citations
12.
Recchia, F., et al.. (2003). Phase I study of liposomal doxorubicin and oxaliplatin as salvage chemotherapy in advanced ovarian cancer. Anti-Cancer Drugs. 14(8). 633–638. 18 indexed citations
13.
14.
Recchia, F., et al.. (2002). Goserelin as ovarian protection in the adjuvant treatment of premenopausal breast cancer: a phase II pilot study. Anti-Cancer Drugs. 13(4). 417–424. 69 indexed citations
15.
Recchia, F., et al.. (2001). Combined 5-Fluorouracil Infusion With Fractionated Epirubicin and Cyclophosphamide in Advanced Breast Cancer. American Journal of Clinical Oncology. 24(4). 392–396. 3 indexed citations
16.
17.
Recchia, F., et al.. (2001). 5-fluorouracil-carboplatin Continuous Infusion as Salvage Chemotherapy in Advanced Cancer. Tumori Journal. 87(6). 383–387. 1 indexed citations
18.
Saggio, Gaetano, et al.. (2001). Primary chemotherapy in stage IV ovarian cancer. A prospective phase II study.. PubMed. 22(4). 287–91. 17 indexed citations
19.
Recchia, F., et al.. (2000). Carboplatin, vindesine, 5-fluorouracil-leucovorin and 13-cis retinoic acid in the treatment of advanced non-small cell lung cancer. A phase II study.. PubMed. 150(4). 269–74. 6 indexed citations
20.
Saggio, Gaetano, et al.. (1999). Chemo-immunotherapy in advanced head and neck cancer.. PubMed. 19(1B). 773–7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pietro Del Medico Breakdown of academic impact, for papers by Alisia Cesta Breakdown of academic impact, for papers by Maria Elena Guerrieri Breakdown of academic impact, for papers by Michela Ballardini Breakdown of academic impact, for papers by Michael A. Bidus Breakdown of academic impact, for papers by Shinichi Tate Breakdown of academic impact, for papers by Nisreen Abu Shahin Breakdown of academic impact, for papers by Maria Grazia Cantù Breakdown of academic impact, for papers by Heng Cui Breakdown of academic impact, for papers by Paweł Basta
Rankless by CCL
2026